Ocular Science® Welcomes Three Esteemed Ophthalmologists to Its Medical Advisory Board

EL SEGUNDO, Calif. (May 23, 2024) – Ocular Science®, a leading biotech company headquartered in Southern California, is delighted to announce the appointment of three distinguished ophthalmologists to its esteemed Medical Advisory Board: Dr. Daniel Pluznik, Dr. Navin Tekwani, and Dr. Alexander de Castro-Abeger.

Daniel Pluznik, MD, brings decades of experience as a board-certified ophthalmologist specializing in premium cataract surgery. As the managing partner at Eye Physicians of Washington in Washington D.C., Dr. Pluznik has earned a reputation for excellence in utilizing the latest technology for lenses and lasers. He has been recognized as a "Top Doc" by Washingtonian Magazine and featured in the Washington Post for his contributions to the field.

Navin Tekwani, MD, born and raised in St. Louis, is a board-certified ophthalmologist and long-time OSRX prescriber renowned for his commitment to delivering optimal eye care. He has been recognized as the #1 Ophthalmologist in Missouri by Newsweek Magazine and actively participates in FDA clinical trials to advance eye care technology. Dr. Tekwani's dedication extends beyond his practice as he annually volunteers for Mission Cataract USA, providing essential cataract surgery to those in need.

Alexander de Castro-Abeger, MD, MBA, a board-certified pediatric ophthalmologist with expertise in pediatric eye diseases and adult strabismus, joins the board as an advocate for patient education and empowerment. With advanced training from Vanderbilt Eye Institute and a commitment to patient advocacy, Dr. de Castro-Abeger brings invaluable insights to the medical advisory board.

"We are thrilled to welcome Dr. Daniel Pluznik, Dr. Navin Tekwani, and Dr. Alexander de Castro-Abeger to our world-class Medical Advisory Board," says Anthony Sampietro, Ocular Science founder and CEO. "Their collective expertise and commitment to advancing eye care will undoubtedly enhance our efforts in producing paradigm-shifting therapeutic solutions in the corrective eye care industry."

The medical advisory board is designed to develop policies and strategies that promote enhanced clinical solutions, products and patient outcomes for Ocular Science and its affiliated companies. The addition of these three esteemed ophthalmologists further strengthens Ocular Science's commitment to shaping the future of visionary care. 

Ocular Science®, headquartered in El Segundo, Calif., is a leading biotech company founded in 2015 by CEO Anthony Sampietro, Chief Medical Officer Damien Goldberg, MD, and Francis Mah, MD. The company focuses on the production, marketing, and sales of compounded ophthalmic products and is guided by a medical advisory board of world leaders in ophthalmology.